Des O Leary

1 result

Dawn Walsh of Kernel Capital; Des O’Leary, CEO of OncoMark; Prof William Gallagher, co-founder of OncoMark; Deirdre Glenn, manager of the life sciences sector at Enterprise Ireland; and Kevin Healy of corporate banking at Bank of Ireland

UCD spinout company OncoMark has raised €2.1 million in funding as it seeks to commercialise a new test for early-stage breast cancer. The company (...)